Stocksigma LogoStocksigma Logo

Jenburkt Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs)

■ Revenue: 4,832 (+6.1% YoY | +36.1% QoQ) ■ EBITDA: 1,302 (-0.7% YoY | +116.0% QoQ) ■ EBITDA Margin (%): 26.9 (-183 bps YoY | +997 bps QoQ) ■ PAT: 1,021

Jenburkt Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs)

Jenburkt Pharmaceuticals Ltd · Financial Result · 03 Nov 2026, 11:26 pm

Jenburkt Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lacs) ■ Revenue: 4,832 (+6.1% YoY | +36.1% QoQ) ■ EBITDA: 1,302 (-0.7% YoY | +116.0% QoQ) ■ EBITDA Margin (%): 26.9 (-183 bps YoY | +997 bps QoQ) ■ PAT: 1,021 (+0.5% YoY | +73.5% QoQ) ■ EPS (INR): 23.1 (+0.4% YoY | +73.4% QoQ)

Original exchange filing (PDF)

More announcements from Jenburkt Pharmaceuticals Ltd

All Jenburkt Pharmaceuticals Ltd announcements